Literature DB >> 16926856

Mechanism of homologous recombination: mediators and helicases take on regulatory functions.

Patrick Sung1, Hannah Klein.   

Abstract

Homologous recombination (HR) is an important mechanism for the repair of damaged chromosomes, for preventing the demise of damaged replication forks, and for several other aspects of chromosome maintenance. As such, HR is indispensable for genome integrity, but it must be regulated to avoid deleterious events. Mutations in the tumour-suppressor protein BRCA2, which has a mediator function in HR, lead to cancer formation. DNA helicases, such as Bloom's syndrome protein (BLM), regulate HR at several levels, in attenuating unwanted HR events and in determining the outcome of HR. Defects in BLM are also associated with the cancer phenotype. The past several years have witnessed dramatic advances in our understanding of the mechanism and regulation of HR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926856     DOI: 10.1038/nrm2008

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  305 in total

1.  Novel attributes of Hed1 affect dynamics and activity of the Rad51 presynaptic filament during meiotic recombination.

Authors:  Valeria Busygina; Dorina Saro; Gareth Williams; Wing-Kit Leung; Amanda F Say; Michael G Sehorn; Patrick Sung; Hideo Tsubouchi
Journal:  J Biol Chem       Date:  2011-11-24       Impact factor: 5.157

Review 2.  RecQ helicases; at the crossroad of genome replication, repair, and recombination.

Authors:  Sarallah Rezazadeh
Journal:  Mol Biol Rep       Date:  2011-09-23       Impact factor: 2.316

3.  Expression, purification and crystallization of Swi5 and the Swi5-Sfr1 complex from fission yeast.

Authors:  Naoyuki Kuwabara; Hiroshi Hashimoto; Noriyo Yamada; Satoru Unzai; Mitsunori Ikeguchi; Mamoru Sato; Yasuto Murayama; Hiroshi Iwasaki; Toshiyuki Shimizu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-08-31

4.  A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization.

Authors:  M Nurul Islam; Nicolas Paquet; David Fox; Eloise Dray; Xiao-Feng Zheng; Hannah Klein; Patrick Sung; Weidong Wang
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

5.  Homologous chromosomes make contact at the sites of double-strand breaks in genes in somatic G0/G1-phase human cells.

Authors:  Manoj Gandhi; Viktoria N Evdokimova; Karen T Cuenco; Marina N Nikiforova; Lindsey M Kelly; James R Stringer; Christopher J Bakkenist; Yuri E Nikiforov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 6.  Molecular mechanisms of activity and derepression of alternative lengthening of telomeres.

Authors:  Hilda A Pickett; Roger R Reddel
Journal:  Nat Struct Mol Biol       Date:  2015-11-04       Impact factor: 15.369

7.  A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition.

Authors:  David A Alagpulinsa; Srinivas Ayyadevara; Shmuel Yaccoby; Robert J Shmookler Reis
Journal:  Mol Cancer Ther       Date:  2015-12-30       Impact factor: 6.261

8.  Promotion of homologous recombination and genomic stability by RAD51AP1 via RAD51 recombinase enhancement.

Authors:  Claudia Wiese; Eloïse Dray; Torsten Groesser; Joseph San Filippo; Idina Shi; David W Collins; Miaw-Sheue Tsai; Gareth J Williams; Bjorn Rydberg; Patrick Sung; David Schild
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

9.  Analysis of the activities of RAD54, a SWI2/SNF2 protein, using a specific small-molecule inhibitor.

Authors:  Julianna S Deakyne; Fei Huang; Joseph Negri; Nicola Tolliday; Simon Cocklin; Alexander V Mazin
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

10.  TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

Authors:  Yang Peng; Hui Dai; Edward Wang; Curtis Chun-Jen Lin; Wei Mo; Guang Peng; Shiaw-Yih Lin
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.